Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia

CD19-CAR T-cell therapy (CART19) causes B-cell aplasia (BCA) and dysgammaglobulinemia but there is a lack of information about the degree of its secondary immunodeficiency. We conducted a prospective study in children and young adults with acute lymphoblastic leukaemia treated with CART19, analysing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Deyà-Martínez, A., Alonso-Saladrigues, A., García, A. P., Faura, A., Torrebadell, M., Vlagea, A., Català, A., Esteve-Solé, A., Juan, M., Rives, S., Alsina, L.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7870804/
https://ncbi.nlm.nih.gov/pubmed/32801317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01027-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados